The global Alagille syndrome market is experiencing significant growth driven by rising awareness, advancements in diagnostic tools, and increased adoption of genetic testing. The market's expansion ...

The EMA has started a review of GSK's treatment candidate for primary biliary cholangitis (PBC), linerixibat, offering hope ...

GSK plc GSK announced that the European Medicines Agency has accepted its marketing authorization application (MAA) seeking ...

In a rare, transcendent concert, the 83-year-old maestro and Verdi specialist put his musical wisdom, lifetime experience and ...

A high-level overview of Mirum Pharmaceuticals, Inc. (MIRM) stock. View (MIRM) real-time stock price, chart, news, analysis, analyst reviews and more.

A signature of Riccardo Muti’s tenure here, the Requiem was performed and recorded to wide acclaim, first through a ...

Fashion is fun, trendy, and always changing. But the rise of fast fashion comes at a heavy cost to our climate and the planet ...

Those therapies are targeted at delaying progression of PBC, rather than focusing specifically on symptoms, so GSK's closest rival is Mirum Pharmaceuticals' oral IBAT inhibitor volixibat, which is ...

Giuseppe Verdi is known as one of the greatest opera composers, whose works today still command wide attention around the ...

Get the latest news and real-time alerts from Mirum Pharmaceuticals, Inc. (MIRM) stock at Seeking Alpha. Skip to content Home page Seeking Alpha - Power to Investors ...

See Mirum Pharmaceuticals, Inc. (MIRM) Environment, Social and Governance Ratings to help you in your stock buying decisions.